Clinical Trial Update: Screening for High Frequency Malignant Disease

View source ↗

Summary

Guardant Health is conducting a clinical trial for screening high-frequency malignant disease, with lung cancer as the listed condition; the study is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Guardant Health, Inc. | Conditions: Lung Cancer | Status: ACTIVE_NOT_RECRUITING